Email
Password
Remember meForgot password?
    Log in with Twitter

article imageU.K. invests £230 million in disease research

By Tim Sandle     Oct 24, 2014 in Health
London - The British government is to partner the Medical Research Council to develop new methods orientated towards identifying the causes of diseases such as cancer and dementia.
News about the £230 million project was made by the Chancellor of the Exchequer, Conservative politician George Osborne, according to Pharma File. Osborne emphasized that the objective was to significantly speed-up the diagnosis and treatment of a range of high profile diseases.
In terms of the technology, these will be so-termed “state of the art technologies” that are intended to understand how differences in the cellular and molecular make-up of people affect how people respond to diseases, and to treatment. In total there are 23 key clinical research projects. The development will take place in 15 universities.
The partnership has been given the title “Clinical Research Infrastructure Initiative.” The £230 million is made up of funding from the British government, Arthritis Research U.K., British Heart Foundation, the Wellcome Trust and Cancer Research U.K. Additional support will be provided by private sector pharma companies.
One example of a project is an investigation onto the causes and treatments of dementia put together by Cardiff University and the Welsh Government. This will use 7Tesla MRI technology. The technology will be used to investigate a range of neurodegenerative conditions.
With a second example, a team from the Institute of Cancer Research, London plan to develop a new instrument called an MR-Linac. This device could not only provide highly accurate visualization of a tumor, tracking the movements of a tumor in real-time within a patient.
More about Disease, Rare disease, Britiain, Genetics, Neurodegenrative disease
More news from
Latest News
Top News